Flavoxate

Flavoxate
Clinical data
AHFS/Drugs.com	Monograph
MedlinePlus	a682706
ATC code	G04BD02 (WHO) ;
Identifiers
	IUPAC name 2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate;
CAS Number	15301-69-6 ;
PubChem CID	3354;
IUPHAR/BPS	7187;
DrugBank	DB01148 ;
ChemSpider	3237 ;
UNII	3E74Y80MEY;
KEGG	D07961 ;
ChEBI	CHEBI:5088 ;
ChEMBL	ChEMBL1493 ;
CompTox Dashboard (EPA)	DTXSID3023053 ;
ECHA InfoCard	100.035.745
Chemical and physical data
Formula	C24H25NO4
Molar mass	391.467 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(OCCN1CCCCC1)c4cccc2c4O/C(=C(\C2=O)C)c3ccccc3;
	InChI InChI=1S/C24H25NO4/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25/h2,4-5,8-12H,3,6-7,13-16H2,1H3 ; Key:SPIUTQOUKAMGCX-UHFFFAOYSA-N ;
	(what is this?) (verify)

Flavoxate is an anticholinergic with antimuscarinic effects. Its muscle relaxant properties may be due to a direct action on the smooth muscle rather than by antagonizing muscarinic receptors.